Dimensional Fund Advisors LP lowered its stake in shares of ICU Medical Inc. (NASDAQ:ICUI) by 4.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 590,804 shares of the company’s stock after selling 28,290 shares during the period. Dimensional Fund Advisors LP owned approximately 3.67% of ICU Medical worth $66,612,000 at the end of the most recent reporting period.
Other institutional investors also recently made changes to their positions in the company. Systematic Financial Management LP raised its position in shares of ICU Medical by 2.5% in the second quarter. Systematic Financial Management LP now owns 17,335 shares of the company’s stock valued at $1,954,000 after buying an additional 430 shares in the last quarter. Teacher Retirement System of Texas raised its position in shares of ICU Medical by 13.8% in the second quarter. Teacher Retirement System of Texas now owns 2,003 shares of the company’s stock valued at $226,000 after buying an additional 243 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of ICU Medical by 69.3% in the second quarter. Victory Capital Management Inc. now owns 366,618 shares of the company’s stock valued at $41,336,000 after buying an additional 150,066 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of ICU Medical by 67.5% in the second quarter. JPMorgan Chase & Co. now owns 309,998 shares of the company’s stock valued at $34,953,000 after buying an additional 124,920 shares in the last quarter. Finally, Janney Montgomery Scott LLC bought a new position in shares of ICU Medical during the second quarter valued at $240,000. Hedge funds and other institutional investors own 89.50% of the company’s stock.
ICU Medical Inc. (NASDAQ:ICUI) traded up 0.47% during midday trading on Friday, hitting $125.58. 30,753 shares of the stock traded hands. The stock’s 50-day moving average price is $124.61 and its 200-day moving average price is $110.92. The stock has a market capitalization of $2.03 billion, a P/E ratio of 37.40 and a beta of 0.49. ICU Medical Inc. has a 52 week low of $85.56 and a 52 week high of $128.93.
ICU Medical (NASDAQ:ICUI) last issued its earnings results on Monday, August 8th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.10. The business earned $96.70 million during the quarter, compared to analysts’ expectations of $89.66 million. ICU Medical had a net margin of 14.94% and a return on equity of 10.33%. The business’s revenue for the quarter was up 15.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.97 earnings per share. Equities research analysts expect that ICU Medical Inc. will post $4.54 EPS for the current fiscal year.
Several equities analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $141.00 price objective on the stock in a report on Wednesday, September 21st. Piper Jaffray Cos. reissued a “neutral” rating and set a $119.00 target price (up from $115.00) on shares of ICU Medical in a research report on Thursday, August 11th.
In other ICU Medical news, Director Joseph R. Saucedo sold 8,000 shares of ICU Medical stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $125.00, for a total value of $1,000,000.00. Following the completion of the transaction, the director now directly owns 8,848 shares of the company’s stock, valued at $1,106,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Joseph R. Saucedo sold 2,000 shares of ICU Medical stock in a transaction dated Friday, July 29th. The stock was sold at an average price of $115.47, for a total transaction of $230,940.00. Following the completion of the transaction, the director now directly owns 4,348 shares of the company’s stock, valued at $502,063.56. The disclosure for this sale can be found here. 15.90% of the stock is currently owned by company insiders.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.